학술논문
Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: Results of a randomized, long-term extension trial (RESTORE2)
Document Type
Article
Source
In: British Journal of Dermatology . (British Journal of Dermatology, June 2013, 168(6):1325-1334)
Subject
Language
English
ISSN
00070963
13652133
13652133